OCTIQ LUBRICANT EYE DROPS- dextran 70 hypromellose solution/ drops 
Innovus Pharmaceuticals, Inc.

----------

Octiq Lubricant Eye  Drops

Active ingredients

Dextran 70 0.1%

Hypromellose 2910 0.3%

Purpose

Lubricant

Lubricant

Uses

Warnings

For external use only

Do not use

When using this product

Stop use and ask a doctor if

Keep out of reach of children 

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

Other Information 

Inactive ingredients

Boric acid, disodium edetate, potassium chloride, povidone, purified water, sodium borate, sodium chloride
Preservative added: benzalkonium choride

Questions?

Call 1.800.996.5122

(Mon-Fri 9AM-5PM EST)

image description

OCTIQ LUBRICANT EYE DROPS 
dextran 70 hypromellose solution/ drops
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:57483-610
Route of AdministrationOPHTHALMIC
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
DEXTRAN 70 (UNII: 7SA290YK68) (DEXTRAN 70 - UNII:7SA290YK68) DEXTRAN 701 mg  in 1 mL
HYPROMELLOSE 2910 (4000 MPA.S) (UNII: RN3152OP35) (HYPROMELLOSE 2910 (4000 MPA.S) - UNII:RN3152OP35) HYPROMELLOSE 2910 (4000 MPA.S)3 mg  in 1 mL
Inactive Ingredients
Ingredient NameStrength
BORIC ACID (UNII: R57ZHV85D4)  
EDETATE DISODIUM (UNII: 7FLD91C86K)  
POTASSIUM CHLORIDE (UNII: 660YQ98I10)  
POVIDONE (UNII: FZ989GH94E)  
WATER (UNII: 059QF0KO0R)  
SODIUM BORATE (UNII: 91MBZ8H3QO)  
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
BENZALKONIUM CHLORIDE (UNII: F5UM2KM3W7)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:57483-610-152 in 1 CARTON11/14/2021
115 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM11/14/2021
Labeler - Innovus Pharmaceuticals, Inc. (962507187)
Establishment
NameAddressID/FEIBusiness Operations
AMMAN PHARMACEUTICAL INDUSTRIES534677849manufacture(57483-610)

Revised: 12/2023
Document Id: 5ca5c652-e112-4803-805b-9207e4474a0e
Set id: 407eeffb-cb32-44bc-aef4-b1b654ac6159
Version: 3
Effective Time: 20231208
 
Innovus Pharmaceuticals, Inc.